BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37374059)

  • 21. Clinical Impact of the Charlson Comorbidity Index on the Efficacy of Salvage Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer.
    Kai K; Nakashima K; Kawakami H; Takeno S; Hishikawa Y; Ikenoue M; Hamada T; Imamura N; Shibata T; Noritomi T; Sasaki F; Nakamura Y; Nanashima A
    Intern Med; 2024 Apr; 63(7):903-910. PubMed ID: 37558484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report.
    Hirose W; Taniyama Y; Fujishima F; Sato C; Unno M; Kamei T
    Int J Surg Case Rep; 2021 Mar; 80():105617. PubMed ID: 33592421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
    Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
    Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of photodynamic therapy for superficial esophageal squamous cell carcinoma in vivo and in vitro.
    Kawazoe K; Isomoto H; Yamaguchi N; Inoue N; Uehara R; Matsushima K; Ichikawa T; Takeshima F; Nonaka T; Nanashima A; Nagayasu T; Uehara M; Asahina I; Nakao K
    Oncol Lett; 2010 Sep; 1(5):877-882. PubMed ID: 22966398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Flor de Lima M; Castro B; Rodríguez-Carrasco M; Libânio D; Pimentel-Nunes P; Sousa O; Dinis-Ribeiro M
    Scand J Gastroenterol; 2022 May; 57(5):525-533. PubMed ID: 34986068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
    Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
    Tani Y; Ishihara R; Matsuura N; Okubo Y; Kawakami Y; Sakurai H; Nakamura T; Matsueda K; Miyake M; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T
    Sci Rep; 2023 Jun; 13(1):10451. PubMed ID: 37380631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer.
    Yano T; Minamide T; Takashima K; Nakajo K; Kadota T; Yoda Y
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yagi K; Toriumi T; Aikou S; Yamashita H; Seto Y
    Ann Gastroenterol Surg; 2021 Jul; 5(4):436-445. PubMed ID: 34337292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
    Chen M; Liu X; Han C; Wang X; Zhao Y; Pang Q; Sun X; Li G; Zhang K; Li L; Qiao X; Lin Y; Chen J; Xiao Z
    BMC Cancer; 2020 Jan; 20(1):36. PubMed ID: 31941487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
    Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
    Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
    Nakajo K; Yoda Y; Hori K; Takashima K; Sinmura K; Oono Y; Ikematsu H; Yano T
    Gastrointest Endosc; 2018 Oct; 88(4):637-646. PubMed ID: 30220299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy.
    Fujishima F; Taniyama Y; Nakamura Y; Okamoto H; Ozawa Y; Ito K; Ishida H; Konno-Kumagai T; Kasajima A; Taniuchi S; Watanabe M; Kamei T; Sasano H
    Dis Esophagus; 2018 Jul; 31(7):. PubMed ID: 29346536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancer.
    Kaneko K; Yano T; Minashi K; Kojima T; Ito M; Satake H; Yajima Y; Yoda Y; Ikematsu H; Oono Y; Hayashi R; Onozawa M; Ohtsu A
    Oncology; 2013; 84(1):57-64. PubMed ID: 23128894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroscopy-Guided Salvage Photodynamic Therapy Combined with Nanoparticle Albumin-Bound Paclitaxel for Locally Advanced Esophageal Cancer after Chemoradiotherapy: A Case Report and Literature Review.
    Zhao W; Zhao J; Kang L; Li C; Xu Z; Li J; Zhang M
    Cancer Biother Radiopharm; 2022 Jun; 37(5):410-416. PubMed ID: 33794100
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective.
    Kim KH; Chang JS; Cha JH; Lee IJ; Kim DJ; Cho BC; Park KR; Lee CG
    Cancer Res Treat; 2017 Jan; 49(1):168-177. PubMed ID: 27338033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma.
    Ohashi S; Kikuchi O; Tsurumaki M; Nakai Y; Kasai H; Horimatsu T; Miyamoto S; Shimizu A; Chiba T; Muto M
    PLoS One; 2014; 9(8):e103126. PubMed ID: 25090101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.